Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.

DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs. Natalie Rahhal. July 2, 2025 at 7:00 AM. Copied; ...

In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is ...

The list price of tirzepatide for weight loss is $1,059.87 per month for six different dose sizes, which is about 20% lower than that of Wegovy, Eli Lilly said in a press release.

Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. While tirzepatide may potentially be more effective, it's too early to know that based on current research.

The active ingredient in the drug, tirzepatide, has already been approved for the treatment of Type 2 diabetes under the name Mounjaro since May 2022. But the FDA's new approval means adults who ...